SCHEMBL29178103

SCHEMBL29178103

O=C(O)Cc1nnc2ccccn2c1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
HPGD P15428 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 1/20 0.47
KDM4E B2RXH2 7/20 0.45
MAPT P10636 2/20 0.44
GLA P06280 3/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.42
ATM Q13315 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
AKR1B1 P15121 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980785 0.79 KDM4E (0.62) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL6288545 0.71 LMNA (0.48) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL17442783 0.69 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL28616292 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
Lithium SCHEMBL30570039 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21577705 0.68 KDM4E (0.61) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL909196 0.68 GGPS1 (0.55) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL16156201 0.67 KMT2A (0.58) ALDH1A1SMN1; SMN2KDM4EGAARXFP1
Hydrochloric Acid SCHEMBL9121777 0.67 GGPS1 (0.54) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD
Hydrochloric Acid SCHEMBL8661446 0.67 GGPS1 (0.54) ALDH1A1SMN1; SMN2RAB9ANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430561-A GPR139 receptor agonist and preparation method thereof 浙江友宁生物医药科技有限公司 2024-01-23 CN disclosed